Patent Application: Autism Symptom Treatment via Neurotensin Receptor Activation

This document is a patent application published by the USPTO, detailing a method for treating autism symptoms through the pharmacological activation of the neurotensin receptor 1 (NTSR1). The application, filed by the New York Institute of Technology, specifically claims formulations that achieve this activation without inducing significant lethargy in the subject. The application number is 19349587, and it was published under the application kind A1 with an expected publication date of March 26, 2026.

As this is a patent application, it does not impose immediate regulatory obligations on companies. However, it signifies potential future intellectual property rights and may influence research and development in the pharmaceutical and biotechnology sectors concerning autism treatments. Companies operating in these areas should monitor the progress of this patent application and related filings for potential licensing opportunities or competitive landscape shifts.